Virginia Retirement Systems’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Virginia Retirement Systems's IBRX Position: Q3 2026 in Review
Virginia Retirement Systems increased its ImmunityBio (IBRX) stake by 2% in Q3 2026, buying an estimated $12K and bringing the position to 76,000 shares worth $717K. The position accounts for ﹤0.01% of the portfolio, ranked #816.
Virginia Retirement Systems first reported a position in IBRX in Q4 2021 and has held it in 6 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Virginia Retirement Systems held 76,000 shares of ImmunityBio worth $717K as of Q3 2026.
- Virginia Retirement Systems bought 1,500 ImmunityBio shares in Q3 2026, an estimated $12K.
- ImmunityBio made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q3 2026, its #816 holding.
- Virginia Retirement Systems first reported a position in ImmunityBio in Q4 2021 and has held it in 6 quarters since.
- 405 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Virginia Retirement Systems's 13F filing for Q3 2026, filed 28 Oct 2026.